What is IMMVF's gross margin?

Immunovia AB (IMMVF) has a gross margin of 36% and a net margin of -5992%.

What is IMMVF's P/E ratio?

Track Immunovia AB (IMMVF) P/E ratio, ROE, and valuation metrics over time.

Where can I see IMMVF's full financials?

See Immunovia AB (IMMVF) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Immunovia AB (IMMVF) Financials — Revenue, Earnings, Cash Flow

Also trades as: IMMNOV.ST (STO) · $vol 0M · 0G8X.L (LSE) · $vol 0M

$0.01

+0.00 (+0.00%)

OTC · Healthcare · Medical - Diagnostics & Research · Tech Score Strong Sell · Power 26 · $3.1M mcap · 296M float · 0.0001% daily turnover

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

📊 Key Metrics

TTM

$1M

Revenue

+31.4% YoY

$-88M

Net Income

+40.1% YoY

$-83M

Free Cash Flow

+6.3% YoY

36.5%

Gross Margin

-6004.7%

Op. Margin

-5991.9%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-425.5%

ROA-212.4%

ROIC808.2%

Valuation

P/E-0.5

P/B2.2

EV/EBITDA0.0

Leverage

Debt/Equity0.14

Current Ratio1.57

Interest Cov.-9.7x

Quality Scores

Piotroski F3/9

Altman Z—

Beneish M0.79